SITARED M 50/500 MG (Sitagliptin (50mg) + Metformin (500mg))

Sitared-M Tablet 50/500 mg is a dual-action medication designed for the management of elevated blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. The formulation aims to mitigate the risk of severe diabetic complications, which could include kidney impairment and vision loss. Furthermore, it may assist in lowering the likelihood of experiencing cardiovascular events such as heart attacks or strokes. Typically, Sitared-M may be utilized as a standalone treatment or in conjunction with other antidiabetic agents for enhanced glycemic control. For optimal results, it should be integrated into a comprehensive treatment plan that includes a balanced diet and consistent physical activity. The prescribed dosage is contingent upon individual health status, pre-existing blood glucose measurements, and potential interactions with concurrent medications. To minimize gastrointestinal discomfort, it is advisable to take the tablet with food. Consistent use at the same time each day is crucial for achieving the best outcomes, and any discontinuation of the medicine should be guided by your healthcare provider’s advice. Adhering to dietary recommendations and exercise regimens suggested by your physician is vital in effectively managing diabetes. While some adverse effects may occur, they often resolve as the body acclimates to the medication. Notably, it is essential to disclose any history of kidney, liver, or heart diseases to your healthcare professional prior to starting this medication. Also, individuals should inform their doctors about all medications they are currently taking to avoid potential drug interactions.